Analysis of current trends in cattle immunoprophylaxis in Poland: national data, European context

Abstract

The aim of this work was to monitor the number of cattle vaccine doses released to the European market by the Polish Official Medicines Control Laboratory (OMCL) between 2022 and 2024, based on data from the batch control database of immunological veterinary medicinal products (IVMPs), including EU certificates issued. The results showed that among the 46 IVMPs in Poland under batch control, inactivated vaccines were the most numerous, representing 50% of the total. Over 282.5 million doses of IVMPs for cattle were released in Poland during this period. Vaccines against infectious bovine rhinotracheitis (IBR) were predominant (>18%), reflecting mandatory control programs in many herds. Products against bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD), Staphylococcus spp. and coliform infections were also common. Although tuberculosis (TB) ranked second, no vaccines against bovine tuberculosis exist - only tuberculin diagnostics are available. Immunopreparations against colibacteriosis were the least frequent (0.04%). These findings illustrate current trends in cattle immunoprophylaxis in Poland and confirm the utility of batch release data for monitoring vaccination practices.